18 results on '"MacKay, Craig"'
Search Results
2. Rethinking our approach to cancer metabolism to deliver patient benefit.
- Author
-
Tardito, Saverio and MacKay, Craig
- Abstract
Altered cellular metabolism is a major mechanism by which tumours support nutrient consumption associated with increased cellular proliferation. Selective dependency on specific metabolic pathways provides a therapeutic vulnerability that can be targeted in cancer therapy. Anti-metabolites have been used clinically since the 1940s and several agents targeting nucleotide metabolism are now well established as standard of care treatment in a range of indications. However, despite great progress in our understanding of the metabolic requirements of cancer and non-cancer cells within the tumour microenvironment, there has been limited clinical success for novel agents targeting pathways outside of nucleotide metabolism. We believe that there is significant therapeutic potential in targeting metabolic processes within cancer that is yet to be fully realised. However, current approaches to identify novel targets, test novel therapies and select patient populations most likely to benefit are sub-optimal. We highlight recent advances in technologies and understanding that will support the identification and validation of novel targets, re-evaluation of existing targets and design of optimal clinical positioning strategies to deliver patient benefit. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
3. Screen detection is a survival predictor independent of pathological grade in colorectal cancer. A prospective cohort study.
- Author
-
Chan, Yen Ming, MacKay, Craig, Ritchie, Duncan T, Scott, Neil, Parnaby, Craig, Murray, Graeme I., and Ramsay, George
- Subjects
- *
COLORECTAL cancer , *PROPORTIONAL hazards models , *COHORT analysis , *LONGITUDINAL method , *MEDICAL screening , *PROGNOSIS , *TUMOR classification - Abstract
Introduction: Patients with screened detected colorectal cancer (CRC) have a better survival than patients referred with symptoms. This may be because of cancers being identified in a younger population and at an earlier stage. In this study, we assess whether screened detected CRC has an improved outcome after controlling for key pathological and patient factors known to influence prognosis.Method: This is a cohort study of all CRC patients diagnosed in NHS Grampian. Patients aged 51-75 years old between June 2007 and July 2017 were included. Data were obtained from a prospectively maintained regional pathology database and outcomes from ISD records. All-cause mortality rates at 1 and 5 years were examined. A Cox proportional hazards regression model was used to estimate the effect of screening status, age, gender, Duke stage, tumour location, extramural venous invasion (EMVI) status and lymph node ratio (LNR) on overall survival.Results: Of 1618 CRC cases, 449 (27.8%) were screened and 1169 (72.2%) were symptomatic. Screened CRC patients had improved survival compared to non-screened CRC at 1 year (88.9% vs 83.9% p < 0.001) and 5-years (42.5% vs 36.2%; p < 0.001). On multivariable analysis of patients who had no neoadjuvant therapy (n = 1272), screening had better survival (HR 0.57; 95% CI 0.44-0.74; p < 0.001). EMVI (HR 2.22; CI 1.76 to 2.79; p < 0.001) and tumour location were found to affect outcome.Conclusion: Patients referred through screening had improved survival compared with symptomatic patients. Further research could be targeted to determine if screened CRC cases are pathologically different to symptomatic cancers or if the screening cohort is inherently more healthy. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
4. E3 Ubiquitin Ligase HOIP Attenuates Apoptotic Cell Death Induced by Cisplatin.
- Author
-
MacKay, Craig, Carroll, Eilís, Ibrahim, Adel F. M., Garg, Amit, Inman, Gareth J., Hay, Ronald T., and Alpi, Arno F.
- Subjects
- *
UBIQUITIN ligases , *CISPLATIN , *APOPTOSIS , *CANCER chemotherapy , *TUMORS , *CANCER cells , *OVARIAN cancer , *ANTINEOPLASTIC agents - Abstract
The genotoxin cisplatin is commonly used in chemotherapy to treat solid tumors, yet our understanding of the mechanism underlying the drug response is limited. In a focused siRNA screen, using an siRNA library targeting genes involved in ubiquitin and ubiquitin-like signaling, we identified the E3 ubiquitin ligase HOIP as a key regulator of cisplatin-induced genotoxicity. HOIP forms, with SHARPIN and HOIL-1L, the linear ubiquitin assembly complex (LUBAC). We show that cells deficient in the HOIP ligase complex exhibit hypersensitivity to cisplatin. This is due to a dramatic increase in caspase-8/caspase-3-mediated apoptosis that is strictly dependent on ATM-, but not ATR-mediated DNA damage checkpoint activation. Moreover, basal and cisplatin-induced activity of the stress response kinase JNK is enhanced in HOIP-depleted cells and, conversely, JNK inhibition can increase cellular resistance to cisplatin and reverse the apoptotic hyperactivation in HOIP-depleted cells. Furthermore, we show that HOIP depletion sensitizes cancer cells, derived from carcinomas of various origins, through an enhanced apoptotic cell death response. We also provide evidence that ovarian cancer cells classified as cisplatin-resistant can regain sensitivity following HOIP downregulation. Cumulatively, our study identifies a HOIP-regulated antiapoptotic signaling pathway, and we envisage HOIP as a potential target for the development of combinatorial chemotherapies to potentiate the efficacy of platinum-based anticancer drugs. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
5. Impact of the Scottish Bowel Cancer Screening Programme on patient and tumour characteristics at a single centre.
- Author
-
Mackay, Craig, Ramsay, George, Rafferty, Anthony, and Loudon, Malcolm
- Subjects
- *
CHI-squared test , *COLON tumors , *LONGITUDINAL method , *MEDICAL referrals , *HEALTH outcome assessment , *SURVIVAL analysis (Biometry) , *DATA analysis software , *DESCRIPTIVE statistics , *EARLY detection of cancer ,RECTUM tumors - Abstract
Aims The Scottish National Bowel Cancer Screening Programme aims to detect asymptomatic colorectal carcinomas and improve outcomes by identifying tumours at an earlier stage. We describe the characteristics of bowel cancers diagnosed through the screening programme since it was established in June 2007 by comparison with colorectal carcinomas from all other referral sources. Methods All patients with colorectal cancer discussed by our regional colorectal multidisciplinary team ( MDT) from June 2007 to August 2011 were included. Patient and tumour characteristics were collated prospectively from MDT records. The database was then reviewed retrospectively. Results During the study 209 916 (58%) of 364 759 invitations to participate in screening were accepted yielding 3895 (1.9%) positive results. The 255 (17%) screening-detected ( SD) patients and 1232 (83%) other referrals ( ORs) were discussed at the MDT within this period. Median age at diagnosis was 65.5 years for SD vs. 71.6 in OR ( P < 0.001) with 64% vs. 53% male [ SD vs. OR ( P < 0.001)]. There were more left-sided tumours in SD ( P = 0.005). Tumours were less advanced in SD group ( P = 0.02) and more likely to undergo a laparoscopic resection ( P = 0.003). Thirty (11.7%) of SD patients were dead at last follow-up compared with 458 (37.2%) of those from other sources ( P < 0.001). Conclusions This cohort from a centre with an established screening programme supports the effect of screening in detecting earlier stage. Those with screen-detected tumours were more likely to survive than patients from the OR group. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
6. High-efficiency lucky imaging.
- Author
-
Mackay, Craig
- Subjects
- *
ASTRONOMICAL observations , *FOURIER analysis , *HIGH resolution imaging , *ASTROPHYSICS - Abstract
Lucky imaging is now an established observing procedure that delivers near-diffraction-limited images in the visible on ground-based telescopes up to ∼2.5 m in diameter. Combined with low-order adaptive optics it can deliver a resolution several times better than that of the Hubble Space Telescope. Many images are taken at high speed as atmospheric turbulent effects appear static on these short time-scales. The sharpest images are selected, shifted and added to give a much higher resolution than is normally possible in ground-based long exposure time observations. The method is relatively inefficient as a significant fraction of the frames are discarded because of their relatively poor quality. This paper shows that a new lucky imaging processing method involving selection in Fourier space can substantially improve the selection percentages. The results show that high-resolution images with a large isoplanatic patch size may be obtained routinely both with conventional lucky imaging and with the new lucky Fourier method. Other methods of improving the sensitivity of the method to faint reference stars are also described. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
7. Putting guidelines into practice: a tailored multi-modal approach to improve post-operative assessments.
- Author
-
Ford, John A., MacKay, Craig, Peach, Chris, Davies, Paul, and Loudon, Malcolm
- Subjects
- *
MEDICAL protocols , *AUDITING , *CHI-squared test , *LONGITUDINAL method , *MEDICAL needs assessment , *POSTOPERATIVE care , *PRE-tests & post-tests , *DESCRIPTIVE statistics , *STANDARDS - Abstract
Background The Scottish Intercollegiate Guideline Network (SIGN) published Postoperative Management in Adults in 2004, advocating post-operative assessments to optimize post-operative care. Our aim was to improve post-operative assessments in a surgical high-dependency unit (HDU). Methods A prospective audit of post-operative admissions to surgical HDU over two 4-week periods was performed. Medical and nursing documentations were reviewed. A tailored multi-modal approach targeting specific barriers to change was used to implement changes; education of staff, introduction of designated HDU bleeps and a post-operative assessment pro forma. Re-audit was performed after 6 months. Main findings The first cycle included 72 patients and the second included 62 patients. Time to assessment improved after changes. Forty-six (74%) patients compared with 27 (37%) patients before were assessed within 4 hours. The number of individual reviews increased and number of reviews due to nursing concerns decreased. Thirty-eight (61%) patients compared with 15 (21%) patients before were assessed through an individual review and one (2%) patient compared with 23 (32%) patients due to nursing concerns. Documentation improved. Documentation of relevant past medical history, medications, allergies, complications and post-operative instructions improved from 2 (3%), 1 (1%), 0, 8 (11%) and 26 (36%), to 18 (29%), 28 (45%), 20 (32%), 18 (29%) and 55 (89%), respectively. Difference between first and second cycles was highly significant throughout ( P < 0.001). Conclusion Clinical practice was improved by a tailored multi-modal approach. Educating staff, improving communication and documentation, and re-audit has shown significant improvement. However, further improvements are required to reach best practice. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
8. Biochemical characterisation of the SWI/SNF family member HLTF
- Author
-
MacKay, Craig, Toth, Rachel, and Rouse, John
- Subjects
- *
BIOCHEMICAL genetics , *DNA replication , *DNA repair , *DNA damage , *UBIQUITIN , *LIGASES , *GENE expression , *CANCER cells - Abstract
Abstract: HLTF is highly similar in domain organisation to yeast Rad5. We identify PTIP and RPA70, both involved in DNA replication and DNA repair, as HLTF-interacting proteins although cells depleted of HLTF did not show defects in cellular responses to DNA damage. In vitro, HLTF has ATPase activity and E3 ubiquitin ligase activity with a range of E2 ubiquitin conjugating enzymes. HLTF expression is severely reduced in a range of cancer cells, and we suggest that the HLTF antibodies generated in this study could be used for cancer diagnostic purposes. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
9. Fast CCD controllers optimize telescope images.
- Author
-
Mackay, Craig D.
- Subjects
- *
CCD cameras - Abstract
Focuses on fast charge-coupled-device (CCD) controllers. Readout noise; Low-contrast capability; Applications; Sensitivity; Adaptive optics for single telescopes.
- Published
- 1996
10. Pathological response post neoadjuvant therapy for locally advanced rectal cancer is an independent predictor of survival.
- Author
-
On, Jason, Shim, Joanna, Mackay, Craig, Murray, Graeme, Samuel, Leslie, Parnaby, Craig, and Ramsay, George
- Subjects
- *
RECTAL cancer , *FORECASTING , *OVERALL survival , *SURVIVAL rate , *MULTIVARIATE analysis , *ONCOLOGIC surgery - Abstract
Aim: Neoadjuvant treatment (NaT) for locally advanced rectal cancer prior to surgery has led to improved outcomes. However, the relationship between pathological response to NaT and survival is not entirely clear. The aim of this study was to assess the degree of pathological response to NaT on survival outcomes. Methods: Clinical and pathological data were collected from a prospectively maintained pathology database between 2005 and 2017. The primary outcome was the overall survival based on pathological response categorized as complete, good partial, partial and minimal. Univariate and multivariate analyses were conducted to identify variables predictive of survival. Cox proportional hazard ratios were used for survival. Results: A total of 596 patients had surgery following NaT for locally advanced rectal cancer. The median follow‐up was 4.57 years (interquartile range 2.21–8.15 years). The overall survival for complete pathological response was 75.6% vs. 37.3% for minimal response (P < 0.001). The overall survival at the end of the study in the good partial vs. partial response groups was 58.9% vs. 39% (P < 0.001). On multivariate analysis, the degree of pathological response remains an independent variable for overall and disease‐specific survival across all categories. Discussion: In addition to other pathological variables, the degree of pathological response to NaT is an independent predictor for survival outcomes. Future verification of these findings elsewhere could support NaT response being used for adjuvant therapy decision making. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
11. Fadraciclib (CYC065), a novel CDK inhibitor, targets key pro-survival and oncogenic pathways in cancer.
- Author
-
Frame, Sheelagh, Saladino, Chiara, MacKay, Craig, Atrash, Butrus, Sheldrake, Peter, McDonald, Edward, Clarke, Paul A., Workman, Paul, Blake, David, and Zheleva, Daniella
- Subjects
- *
PHARMACOLOGY , *MYELOID leukemia , *RNA polymerase II , *MYELODYSPLASTIC syndromes , *ONCOGENIC proteins , *HEMATOLOGIC malignancies , *RNA polymerases , *CD20 antigen - Abstract
Cyclin-dependent kinases (CDKs) contribute to the cancer hallmarks of uncontrolled proliferation and increased survival. As a result, over the last two decades substantial efforts have been directed towards identification and development of pharmaceutical CDK inhibitors. Insights into the biological consequences of CDK inhibition in specific tumor types have led to the successful development of CDK4/6 inhibitors as treatments for certain types of breast cancer. More recently, a new generation of pharmaceutical inhibitors of CDK enzymes that regulate the transcription of key oncogenic and pro-survival proteins, including CDK9, have entered clinical development. Here, we provide the first disclosure of the chemical structure of fadraciclib (CYC065), a CDK inhibitor and clinical candidate designed by further optimization from the aminopurine scaffold of seliciclib. We describe its synthesis and mechanistic characterization. Fadraciclib exhibits improved potency and selectivity for CDK2 and CDK9 compared to seliciclib, and also displays high selectivity across the kinome. We show that the mechanism of action of fadraciclib is consistent with potent inhibition of CDK9-mediated transcription, decreasing levels of RNA polymerase II C-terminal domain serine 2 phosphorylation, the pro-survival protein Myeloid Cell Leukemia 1 (MCL1) and MYC oncoprotein, and inducing rapid apoptosis in cancer cells. This cellular potency and mechanism of action translate to promising anti-cancer activity in human leukemia mouse xenograft models. Studies of leukemia cell line sensitivity identify mixed lineage leukemia (MLL) gene status and the level of B-cell lymphoma 2 (BCL2) family proteins as potential markers for selection of patients with greater sensitivity to fadraciclib. We show that the combination of fadraciclib with BCL2 inhibitors, including venetoclax, is synergistic in leukemic cell models, as predicted from simultaneous inhibition of MCL1 and BCL2 pro-survival pathways. Fadraciclib preclinical pharmacology data support its therapeutic potential in CDK9- or CDK2-dependent cancers and as a rational combination with BCL2 inhibitors in hematological malignancies. Fadraciclib is currently in Phase 1 clinical studies in patients with advanced solid tumors (NCT02552953) and also in combination with venetoclax in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) (NCT03739554) and relapsed refractory acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) (NCT04017546). [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
12. Can Haematology Blood Tests at Time of Diagnosis Predict Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer?
- Author
-
Ramsay, George, Ritchie, Duncan T., MacKay, Craig, Parnaby, Craig, Murray, Graeme, and Samuel, Leslie
- Subjects
- *
RECTAL cancer , *BLOOD cell count , *BLOOD testing , *HEMATOLOGY , *LEUCOCYTES , *RECTAL prolapse - Abstract
Background: Outcomes in locally advanced rectal cancer are improved by neoadjuvant therapy followed by surgical resection. Some patients respond completely to preoperative treatment. Therefore, predicting the pathological response to preoperative therapy is of clinical importance. Accurate prediction would allow for tailored approaches to neoadjuvant therapy. Methods: All patients undergoing resection of rectal adenocarcinoma after neoadjuvant therapy between 2006 and 2015 were included in this cohort study. Patients were identified from a prospectively collected database and data were supplemented retrospectively with full blood count at diagnosis. Specimens resected following neoadjuvant therapy were graded according to pathological response. Follow-up data was obtained from the national registry. The primary outcome was complete pathological response. Results: Of 330 patients, 71 (21.5%) responded completely to preoperative therapy. Median age was 66 and 65% were male (n = 215). White cell count (WCC) was the most predictive marker, for predicting pCR; area under the curve (AUC) 0.666. This was higher than neutrophil/platelet ratio (AUC 0.652) or neutrophil/lymphocyte ratios (AUC = 0.437). Kaplan-Meier survival analysis showed those patients with WCC > 8 had poorer survival than those with WCC < 8 (p = 0.009). Conclusion: Routinely collected haematology samples at the point of diagnosis can assist in predicting for complete response to neoadjuvant therapy. Although novel biomarkers will have a greater predictive value, this clinically available value test could help to assist in risk stratification of patients using routinely collected laboratory tests. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
13. Prolonged Ileus after Colorectal Surgery, a Systematic Review.
- Author
-
Shereef, Anzil, Raftery, David, Sneddon, Fraser, Emslie, Katy, Mair, Lyn, Mackay, Craig, Ramsay, George, and Forget, Patrice
- Subjects
- *
PROCTOLOGY , *BOWEL obstructions , *NOSOCOMIAL infections , *POSTOPERATIVE period , *RANDOMIZED controlled trials - Abstract
Background: The development of prolonged post-operative ileus (POI) remains a significant problem in the general surgical patient population. The aetiology of ileus is poorly understood and management options/preventative measures are currently extremely limited. The pathophysiology leading to a post-operative ileus is relatively poorly understood, and there is no validated method to estimate ileus occurrence or duration. Ileus in the post-operative period commonly occurs following major colorectal surgery and leads to painful abdominal distension, vomiting, nutritional deficit, pneumonia, prolonged hospital stays and susceptibility to hospital-acquired infection. An increased hospital stay, the burden of treatment costs and the burden on the health system highlight the importance of future research on finding definitions, preventions and predictions of ileus. Methods: A systematic literature review was performed to identify randomized controlled trials (RCTs) comparing the rate of ileus on various treatments for prolonged post-operative ileus following colorectal surgery. A confidence evaluation in a meta-analysis were performed using CINeMA. Direct and indirect comparisons of all interventions were simultaneously carried out using a network meta-analysis. The level of certainty was appraised using the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) approach. The method of assessing the risk of bias, the quality assessment, used the Cochrane Risk of Bias 2 tool (RoB2). Results: Among the seven included studies, the majority suffered from considerable within-study bias, affecting the confidence rates of study findings. Heterogeneity and incoherence made the pairwise meta-analysis and ranking of interventions unfeasible. Indirect comparisons were considered unreliable due to this incoherence. Conclusions: This systematic review, with a confidence evaluation in the network meta-analysis, determined that there is a knowledge gap in the field of study on prolonged ileus following digestive surgery. The current evidence suffers from heterogeneity and incoherence more than imprecision. There is a gap in the data on ileus occurrence in interventional trials for digestive surgery. This could inform clinicians and trialists to better appraise the current literature and plan future trials. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
14. The simultaneous use of multiple imaging techniques to investigate the nature and localisation of radioactivity within micro-structures surrounding the rat brain.
- Author
-
Stevenson, Karen, Mackay, Craig, Brogan, Lyndsay, Molander-Melin, Marie, Gardiner, Philip, Aberg, Per, and Larsson, Bengt
- Published
- 2014
- Full Text
- View/download PDF
15. Disease recurrence after right hemicolectomy in Scotland: Is there rationale to adopt complete mesocolic excision (CME)?
- Author
-
H M Metcalfe, Kiloran, Knight, Katrina, McIntosh, Stuart, Hunter, Ross, MacKay, Craig, McCabe, Gerard, Sahni, Dhruv, Ramsay, George, Roxburgh, Campbell, and Richards, Colin
- Subjects
- *
RIGHT hemicolectomy , *DISEASE relapse , *SURGICAL emergencies , *CANCER patients , *COLON cancer , *CANCER prognosis , *DIVERTICULOSIS , *COLON tumors , *LYMPHADENECTOMY , *COLECTOMY , *ARTHRITIS Impact Measurement Scales , *CANCER relapse , *TREATMENT effectiveness , *LAPAROSCOPY , *GLASGOW Coma Scale , *RESEARCH funding ,MESENTERY surgery - Abstract
Aims: Complete mesocolic excision (CME) has been proposed as a way to improve the oncological outcomes in patients with colon cancer. To investigate whether there is rationale for adopting the technique in Scotland, our aim was to define the incidence of disease recurrence following standard right hemicolectomy and to compare this with published CME outcomes.Methods: Data was collected on consecutive patients undergoing right or extended right hemicolectomy for colonic adenocarcinoma (2012-2017) at three hospitals in Scotland (Raigmore Hospital, Aberdeen Royal Infirmary and Glasgow Royal Infirmary). Emergency or palliative surgery was excluded. Patients were followed up with CT scans and colonoscopy for a minimum of 3 years.Results: 689 patients (M 340, F 349) were included. 30-day mortality was 1.6%. Final pathological stage was Stage I (14%), Stage II (49.8%) and Stage III (36.1%). During follow-up, 10.5% developed loco-regional recurrence and 12.2% developed distant metastases. The 1, 3 and 5-year disease-free survival (DFS) was 94%, 84% and 82% respectively. Primary determinants of recurrence were T stage (p < 0.001), N stage (p < 0.001), apical node involvement (p < 0.001) and EMVI (p < 0.001). When compared to the literature, 30-day mortality was lower than many published series and DFS rates were similar to the largest CME study to date (4 year DFS 85.8% versus 83%).Conclusion: The outcomes of patients undergoing right hemicolectomy in Scotland compare favourably with many published CME studies. The technique demands further evaluation before it can be recommended for adoption into routine surgical practice. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
16. The Fanconi Anaemia Components UBE2T and FANCM Are Functionally Linked to Nucleotide Excision Repair.
- Author
-
Kelsall, Ian R., Langenick, Judith, MacKay, Craig, Patel, Ketan J., and Alpi, Arno F.
- Subjects
- *
ANEMIA , *NUCLEIC acids , *UBIQUITIN , *DNA damage , *NUCLEOTIDES , *GENETIC mutation - Abstract
The many proteins that function in the Fanconi anaemia (FA) monoubiquitylation pathway initiate replicative DNA crosslink repair. However, it is not clear whether individual FA genes participate in DNA repair pathways other than homologous recombination and translesion bypass. Here we show that avian DT40 cell knockouts of two integral FA genes - UBE2T and FANCM are unexpectedly sensitive to UV-induced DNA damage. Comprehensive genetic dissection experiments indicate that both of these FA genes collaborate to promote nucleotide excision repair rather than translesion bypass to protect cells form UV genotoxicity. Furthermore, UBE2T deficiency impacts on the efficient removal of the UV-induced photolesion cyclobutane pyrimidine dimer. Therefore, this work reveals that the FA pathway shares two components with nucleotide excision repair, intimating not only crosstalk between the two major repair pathways, but also potentially identifying a UBE2T-mediated ubiquitin-signalling response pathway that contributes to nucleotide excision repair. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
17. Infrared observations of gravitational lensing in Abell 2219 with CIRSI.
- Author
-
Gray, Meghan E., Ellis, Richard S., Refregier, Alexandre, Bézecourt, Jocelyn, McMahon, Richard G., Beckett, Martin G., Mackay, Craig D., and Hoenig, Michael D.
- Subjects
- *
GRAVITATIONAL lenses , *INFRARED astronomy , *POSSIBILITY - Abstract
We present the first detection of a gravitational depletion signal at near-infrared wavelengths, based on deep panoramic images of the cluster Abell 2219 (z=0.22) taken with the Cambridge Infrared Survey Instrument (CIRSI) at the prime focus of the 4.2-m William Herschel Telescope. Infrared studies of gravitational depletion offer a number of advantages over similar techniques applied at optical wavelengths, and can provide reliable total masses for intermediate-redshift clusters. Using the maximum-likelihood technique developed by Schneider, King & Erben, we detect the gravitational depletion at the 3σ confidence level. By modelling the mass distribution as a singular isothermal sphere and ignoring the uncertainty in the unlensed number counts, we find an Einstein radius of [equation] (66 per cent confidence limit). This corresponds to a projected velocity dispersion of σ[sub v]∼800 km s[sup -1], in agreement with constraints from strongly lensed features. For a Navarro, Frenk & White mass model, the radial dependence observed indicates a best-fitting halo scalelength of 125h[sup -1] kpc. We investigate the uncertainties arising from the observed fluctuations in the unlensed number counts, and show that clustering is the dominant source of error. We extend the maximum-likelihood method to include the effect of incompleteness, and discuss the prospects of further systematic studies of lensing in the near-infrared band. [ABSTRACT FROM AUTHOR]
- Published
- 2000
- Full Text
- View/download PDF
18. Towards high-resolution astronomical imaging.
- Author
-
Buscher, David, Chowdhury, Nahid, Davies, Ric, Hinkley, Sasha, Hubin, Norbert, Jorden, Paul, Mackay, Craig, Massey, Richard, O'Brien, Kieran, Parry, Ian, and Skottfelt, Jesper
- Subjects
- *
INFRARED imaging , *IMAGE - Abstract
Craig Mackay reports from a recent meeting on "The future of high-resolution imaging in the visible and infrared", reviewing the astronomical drivers for development and the technological advances that might boost performance. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.